VACCINS ADAPTATIFS CIBLÉS
- 专利权人:
- Inc.;Modernatx
- 发明人:
- 申请号：
- EP16808481.2
- 公开号：
- EP3307305A4
- 申请日:
- 2016.06.10
- 申请国别(地区):
- EP
- 年份:
- 2019
- 代理人:
- 摘要：
- The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules encoding targeted adaptive vaccines (TAVs), such as PCSK9 TAVs, TNF alpha TAVs, IL-17A TAVs, or GDF8 TAVs.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- שימוש במעכב tnfa לטיפול בפוליאריטריטיס מכרסם
- RNAi-Mediated inhibition of tumor necrosis factor alpha-related conditions
- RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR &alpha；-RELATED CONDITIONS
- strongly inactivated yet highly immunogenic vaccine and manufacturing process
- PROTEINA QUIMERICA COMPUESTA DEL DOMINIO ANTAGONISTA DE FACTOR DE CRECIMIENTO NERVIOSO SECRETADO (NGF) Y UN DOMINIO ANTAGONISTA DE FACTOR ALFA DE NECROSIS TUMORAL (TNFA).
